Na Li

机构：Macau University of Science and Technology, Beijing Tongren Hospital, Xinjiang Agricultural University, University of Calgary, Xuzhou Medical College, Capital Medical University, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Huaian First People’s Hospital, Second Affiliated Hospital of Dalian Medical University, Tianjin People's Hospital, Second People’s Hospital of Huai’an, The Ohio State University, Xinjiang University, McMaster University · ORCID：0000-0003-3619-7899

发表论文 187 篇 · 总被引 6442 次 · h-index 31

代表论文

• Identification of a Biomarker Panel in Extracellular Vesicles Derived From Non‐Small Cell Lung Cancer (NSCLC) Through Proteomic Analysis and Machine Learning (2025 · Journal of Extracellular Vesicles · 被引 13)
• SREBP-1 increases glucose uptake to promote tumor resistance to lysosome inhibition (2026 · Science Translational Medicine · 被引 3)
• EV-A71 invades the central nervous system and affects the blood-brain barrier in a tree shrew model (2025 · Frontiers in Immunology · 被引 3)
• Design, Synthesis, and Biological Evaluation of Selective PAK4 Degrader for the Treatment of Lung Tumor Metastasis (2025 · Journal of Medicinal Chemistry · 被引 3)
• Exploring the standardization of human nasal antibody measurements (2025 · Emerging Microbes & Infections · 被引 3)
• Mitochondria-targeted hybrid nanovesicles trigger immunogenic cell death and remodel tumor neutrophils for enhanced colorectal cancer immunotherapy (2025 · Journal of Controlled Release · 被引 2)